Contineum Therapeutics (CTNM) Leases: 2023-2025
Historic Leases for Contineum Therapeutics (CTNM) over the last 2 years, with Sep 2025 value amounting to $4.8 million.
- Contineum Therapeutics' Leases was N/A to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year change of. This contributed to the annual value of $5.5 million for FY2024, which is 660.36% up from last year.
- Per Contineum Therapeutics' latest filing, its Leases stood at $4.8 million for Q3 2025, which was down 4.65% from $5.0 million recorded in Q2 2025.
- In the past 5 years, Contineum Therapeutics' Leases ranged from a high of $5.5 million in Q4 2024 and a low of $231,000 during Q2 2024.
- For the 3-year period, Contineum Therapeutics' Leases averaged around $3.1 million, with its median value being $4.8 million (2025).
- Data for Contineum Therapeutics' Leases shows a peak YoY surged of 2,067.53% (in 2025) over the last 5 years.
- Quarterly analysis of 3 years shows Contineum Therapeutics' Leases stood at $719,000 in 2023, then skyrocketed by 660.36% to $5.5 million in 2024, then soared by 2,067.53% to $4.8 million in 2025.
- Its Leases was $4.8 million in Q3 2025, compared to $5.0 million in Q2 2025 and $5.2 million in Q1 2025.